268 related articles for article (PubMed ID: 22388100)
1. Delineating an epigenetic continuum in head and neck cancer.
Worsham MJ; Stephen JK; Chen KM; Havard S; Shah V; Gardner G; Schweitzer VG
Cancer Lett; 2014 Jan; 342(2):178-84. PubMed ID: 22388100
[TBL] [Abstract][Full Text] [Related]
2. [Epigenetic aspects in carcinomas of the head and neck].
Schmezer P; Plass C
HNO; 2008 Jun; 56(6):594-602. PubMed ID: 18483718
[TBL] [Abstract][Full Text] [Related]
3. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
6. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation in head and neck tumorigenesis.
Stephen JK; Chen KM; Havard S; Harris G; Worsham MJ
Methods Mol Biol; 2012; 863():187-206. PubMed ID: 22359294
[TBL] [Abstract][Full Text] [Related]
8. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Gollin SM
Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
11. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
Zhang HZ; Shan CG; Huang AP; Wang JM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
13. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
14. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
[TBL] [Abstract][Full Text] [Related]
16. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
17.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.
Calmon MF; Rodrigues RV; Kaneto CM; Moura RP; Silva SD; Mota LD; Pinheiro DG; Torres C; de Carvalho AF; Cury PM; Nunes FD; Nishimoto IN; Soares FA; da Silva AM; Kowalski LP; Brentani H; Zanelli CF; Silva WA; Rahal P; Tajara EH; Carraro DM; Camargo AA; Valentini SR
Neoplasia; 2009 Dec; 11(12):1329-39. PubMed ID: 20019841
[TBL] [Abstract][Full Text] [Related]
19. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Modifications in Head and Neck Cancer.
Gaździcka J; Gołąbek K; Strzelczyk JK; Ostrowska Z
Biochem Genet; 2020 Apr; 58(2):213-244. PubMed ID: 31712935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
